XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Oct. 30, 2021
Summary of Restricted Stock Awards Transactions

The following table summarizes transactions for our restricted stock and other stock awards:

 

 

 

Number of

Shares

 

 

Weighted-

Average Grant

Date Fair Value

 

Outstanding at January 30, 2021

 

 

0

 

 

$

0.00

 

Granted

 

 

8,702

 

 

 

32.79

 

Vested

 

 

(802

)

 

 

33.04

 

Forfeited or expired

 

 

0

 

 

 

0.00

 

Outstanding at October 30, 2021

 

 

7,900

 

 

$

32.76

 

 

Summary of SARs Activity

The following table summarizes the SARs activity:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise Price

 

 

Weighted-

Average

Remaining

Contractual

Term (Years)

 

Outstanding at January 30, 2021

 

 

88,400

 

 

$

7.61

 

 

 

 

 

Granted

 

 

93,800

 

 

 

30.94

 

 

 

 

 

Forfeited or expired

 

 

(5,800

)

 

 

30.94

 

 

 

 

 

Exercised

 

 

(88,400

)

 

 

7.61

 

 

 

 

 

Outstanding at October 30, 2021

 

 

88,000

 

 

$

30.94

 

 

 

2.4

 

Schedule of SARs Assumptions

The fair value was estimated using a trinomial lattice model with the following assumptions:

 

 

 

October 30, 2021

 

 

October 31, 2020

 

Risk free interest rate yield curve

 

0.06% - 1.18%

 

 

0.08% - 0.38%

 

Expected dividend yield

 

0.8%

 

 

1.2%

 

Expected volatility

 

63.29%

 

 

64.09%

 

Maximum life

 

2.4 Years

 

 

1.9 Years

 

Exercise multiple

 

 

1.03

 

 

 

1.29

 

Maximum payout

 

$

5.00

 

 

$

5.00

 

Employee exit rate

 

2.2% - 9.0%

 

 

2.2% - 9.0%

 

Restricted Stock Units and Performance Stock Units [Member]  
Summary of Stock Compensation Expense

The following table summarizes information regarding stock-based compensation expense recognized for all share-settled equity awards (restricted stock units, performance stock units and restricted stock and other stock awards):

 

(In thousands)

 

Thirteen

Weeks Ended October 30, 2021

 

 

Thirteen

Weeks Ended October 31, 2020

 

 

Thirty-nine

Weeks Ended October 30, 2021

 

 

Thirty-nine

Weeks Ended October 31, 2020

 

Stock-based compensation expense before the

   recognized income tax effect

 

$

1,356

 

 

$

797

 

 

$

3,876

 

 

$

2,667

 

Income tax effect at statutory rate

 

$

(337

)

 

$

(213

)

 

$

(975

)

 

$

(613

)

Additional income tax (benefit)/expense on vesting of awards

 

$

(107

)

 

$

3

 

 

$

(992

)

 

$

81

 

Stock Appreciation Rights (SARs) [Member]  
Summary of Stock Compensation Expense

The following table summarizes information regarding stock-based compensation expense recognized for SARs:

 

(In thousands)

 

Thirteen

Weeks Ended October 30, 2021

 

 

Thirteen

Weeks Ended October 31, 2020

 

 

Thirty-nine

Weeks Ended October 30, 2021

 

 

Thirty-nine

Weeks Ended October 31, 2020

 

Stock-based compensation expense before the

   recognized income tax effect

 

$

71

 

 

$

183

 

 

$

220

 

 

$

187

 

Income tax effect at statutory rate

 

$

(18

)

 

$

(49

)

 

$

(55

)

 

$

(43

)

Restricted Stock Units and Performance Stock Units [Member]  
Summary of Restricted Stock Awards Transactions

The following table summarizes transactions for our restricted stock units and performance stock units:

 

 

 

Number of

Shares

 

 

Weighted-

Average Grant

Date Fair Value

 

Outstanding at January 30, 2021

 

 

513,016

 

 

$

11.07

 

Granted

 

 

215,972

 

 

 

28.21

 

Vested

 

 

(238,964

)

 

 

15.50

 

Forfeited

 

 

(34,486

)

 

 

16.17

 

Outstanding at October 30, 2021

 

 

455,538

 

 

$

16.48